Risk adjustment has many variables and cannot always level the playing field between hospitals, said Ashish K. Jha, MD, MPH, the K.T. Li Professor of Health Policy at the Harvard T.H. Chan School of Public Health and the director of the Harvard Global Health Institute.
Risk adjustment has many variables and cannot always level the playing field between hospitals, said Ashish K. Jha, MD, MPH, the K.T. Li Professor of Health Policy at the Harvard T.H. Chan School of Public Health and the director of the Harvard Global Health Institute.
Transcript (slightly modified)
The CMS star ratings for hospitals are adjusted for each hospital’s case mix, but how might risk adjustment methods fail to level the playing field?
So case mix, or risk adjustment, is a standard methodology that we use to try to equalize the playing field between organizations that take care of a lot of sick people, and organizations that take care of fewer sick people. And what we know is that our ability to measure case mix, our ability to measure the severity of illness, sort of varies by condition. It varies based on what kind of data you’re using. So when you use claims data, and for instance if you’re looking at readmissions, we know that risk adjustment really is not good at all. Whereas claims data for, risk adjustment for, heart attack deaths actually is pretty good.
So there isn’t a blanket criticism of risk adjustment that somehow it never works or it always works or it’s always bad for certain conditions. It just depends on the measure you’re looking at. And what we know is that a lot of the measures that went into the star ratings, they’re just, we don’t do a good job of risk adjustment on those, and we can tell because when we look at the hospitals that care for the sickest patients, they tend to be some of the worst performers.
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Strategies for Improving Patient Access to Dermatology Care
March 22nd 2025Elizabeth Jones, MD, FAAD, highlights the persistent issue of insurance companies favoring expensive, newer medications over equally effective generics in dermatology, emphasizing the time-consuming prior authorization process and advocating for patient partnerships and systemic improvements.
Read More
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More